297 related articles for article (PubMed ID: 16633143)
1. Reboxetine versus fluvoxamine in the treatment of motor vehicle accident-related posttraumatic stress disorder: a double-blind, fixed-dosage, controlled trial.
Spivak B; Strous RD; Shaked G; Shabash E; Kotler M; Weizman A
J Clin Psychopharmacol; 2006 Apr; 26(2):152-6. PubMed ID: 16633143
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of reboxetine compared with citalopram: a double-blind study in patients with major depressive disorder.
Langworth S; Bodlund O; Agren H
J Clin Psychopharmacol; 2006 Apr; 26(2):121-7. PubMed ID: 16633139
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
Otsubo T; Akimoto Y; Yamada H; Koda R; Aoyama H; Tanaka K; Mimura M; Nakagome K; Kamijima K
Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
[TBL] [Abstract][Full Text] [Related]
4. Demographic and clinical characteristics of motor vehicle accident victims in the community general health outpatient clinic: a comparison of PTSD and non-PTSD subjects.
Kupchik M; Strous RD; Erez R; Gonen N; Weizman A; Spivak B
Depress Anxiety; 2007; 24(4):244-50. PubMed ID: 17001628
[TBL] [Abstract][Full Text] [Related]
5. Resolution of sexual dysfunction during double-blind treatment of major depression with reboxetine or paroxetine.
Baldwin D; Bridgman K; Buis C
J Psychopharmacol; 2006 Jan; 20(1):91-6. PubMed ID: 16204325
[TBL] [Abstract][Full Text] [Related]
6. Fluvoxamine prevents recurrence of depression: results of a long-term, double-blind, placebo-controlled study.
Terra JL; Montgomery SA
Int Clin Psychopharmacol; 1998 Mar; 13(2):55-62. PubMed ID: 9669185
[TBL] [Abstract][Full Text] [Related]
7. Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: results of a fixed-dose, placebo-controlled study.
Martenyi F; Brown EB; Caldwell CD
J Clin Psychopharmacol; 2007 Apr; 27(2):166-70. PubMed ID: 17414240
[TBL] [Abstract][Full Text] [Related]
8. An open-label study of mirtazapine as treatment for combat-related PTSD.
Alderman CP; Condon JT; Gilbert AL
Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388
[TBL] [Abstract][Full Text] [Related]
9. An open-label pilot study of fluvoxamine for mixed anxiety-depression.
Houck C
Psychopharmacol Bull; 1998; 34(2):225-7. PubMed ID: 9641005
[TBL] [Abstract][Full Text] [Related]
10. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.
Erzegovesi S; Guglielmo E; Siliprandi F; Bellodi L
Eur Neuropsychopharmacol; 2005 Jan; 15(1):69-74. PubMed ID: 15572275
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study.
Davidson J; Rothbaum BO; Tucker P; Asnis G; Benattia I; Musgnung JJ
J Clin Psychopharmacol; 2006 Jun; 26(3):259-67. PubMed ID: 16702890
[TBL] [Abstract][Full Text] [Related]
12. Effects of mirtazapine in patients with post-traumatic stress disorder in Korea: a pilot study.
Bahk WM; Pae CU; Tsoh J; Chae JH; Jun TY; Chul-Lee ; Kim KS
Hum Psychopharmacol; 2002 Oct; 17(7):341-4. PubMed ID: 12415552
[TBL] [Abstract][Full Text] [Related]
13. Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder.
McRae AL; Brady KT; Mellman TA; Sonne SC; Killeen TK; Timmerman MA; Bayles-Dazet W
Depress Anxiety; 2004; 19(3):190-6. PubMed ID: 15129422
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of efficacy and safety of reboxetine in elderly patients affected by "retarded" post-stroke depression. A random, placebo-controlled study.
Rampello L; Alvano A; Chiechio S; Raffaele R; Vecchio I; Malaguarnera M
Arch Gerontol Geriatr; 2005; 40(3):275-85. PubMed ID: 15814161
[TBL] [Abstract][Full Text] [Related]
15. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population.
Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F
J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347
[TBL] [Abstract][Full Text] [Related]
16. Reboxetine for the treatment of patients with Cocaine Dependence Disorder.
Szerman N; Peris L; Mesías B; Colis P; Rosa J; Prieto A;
Hum Psychopharmacol; 2005 Apr; 20(3):189-92. PubMed ID: 15799010
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
18. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
Volkers AC; Tulen JH; van den Broek WW; Bruyn JA; Passchier J; Pepplinkhuizen L
Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
[TBL] [Abstract][Full Text] [Related]
19. Tianeptine in the combined treatment of combat related posttraumatic stress disorder.
Frančišković T; Suković Z; Janović S; Stevanović A; Nemčić-Moro I; Rončević-Gržeta I; Letica-Crepulja M
Psychiatr Danub; 2011 Sep; 23(3):257-63. PubMed ID: 21963693
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial.
Cohen-Yavin I; Yoran-Hegesh R; Strous RD; Kotler M; Weizman A; Spivak B
Clin Neuropharmacol; 2009; 32(4):179-82. PubMed ID: 19644227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
